Amoxicillin Dosing for a 5-Year-Old Weighing 16.78 kg
For this child, prescribe amoxicillin 375 mg (approximately 3.75 mL of the 400 mg/5 mL suspension) twice daily, which delivers 45 mg/kg/day for mild to moderate respiratory tract infections, or 750 mg (7.5 mL) twice daily for severe infections or high pneumococcal resistance areas, delivering 90 mg/kg/day. 1
Dosing Algorithm Based on Clinical Indication
For Mild to Moderate Respiratory Infections
- The standard dose is 45 mg/kg/day divided into 2 doses (every 12 hours). 1, 2
- For a 16.78 kg child: 16.78 kg × 45 mg/kg/day = 755 mg/day total, which equals 377.5 mg per dose (approximately 3.75 mL twice daily using 400 mg/5 mL suspension). 1
- This regimen provides adequate coverage for Streptococcus pneumoniae, non-β-lactamase-producing Haemophilus influenzae, and Streptococcus pyogenes. 1
For Severe Infections or High Pneumococcal Resistance
- Use the high-dose regimen of 90 mg/kg/day divided into 2 doses when any of these risk factors are present: 1
- Age < 2 years
- Daycare attendance
- Recent antibiotic use (within past 30 days)
- Geographic area with > 10% penicillin-resistant S. pneumoniae
- Moderate-to-severe illness presentation
- For a 16.78 kg child: 16.78 kg × 90 mg/kg/day = 1,510 mg/day total, which equals 755 mg per dose (approximately 7.5 mL twice daily). 1, 3
- This high-dose regimen achieves concentrations sufficient to overcome penicillin-resistant S. pneumoniae with MICs up to 2–4 mg/L. 1
Indication-Specific Dosing
Community-Acquired Pneumonia
- Children < 5 years old: Use 90 mg/kg/day in 2 doses (755 mg or 7.5 mL twice daily for this child) to ensure coverage of penicillin-resistant S. pneumoniae. 1, 3
- Treatment duration: 10 days for pneumonia, with clinical improvement expected within 48–72 hours. 1
Group A Streptococcal Pharyngitis
- Dose: 50–75 mg/kg/day in 2 doses for 10 days (maximum 1,000 mg per dose). 1
- For this 16.78 kg child: 840–1,260 mg/day total, which equals 420–630 mg per dose (approximately 4–6 mL twice daily). 1
- The full 10-day course must be completed to prevent acute rheumatic fever, even if symptoms resolve earlier. 1
Acute Bacterial Sinusitis
- Children ≥ 2 years without risk factors: 45 mg/kg/day (375 mg or 3.75 mL twice daily). 1
- Children < 2 years, daycare attendees, or recent antibiotic use: 80–90 mg/kg/day (755 mg or 7.5 mL twice daily). 1
Practical Administration Instructions
- Administer at the start of a meal to minimize gastrointestinal intolerance. 2
- Shake the suspension well before each use and measure doses accurately with an oral syringe or dosing cup. 2
- The suspension may be mixed with formula, milk, fruit juice, water, or cold drinks if needed, but must be consumed immediately after mixing. 2
- Refrigeration is preferable but not required; discard any unused suspension after 14 days. 2
Treatment Duration and Monitoring
- Minimum treatment duration: 48–72 hours beyond symptom resolution or evidence of bacterial eradication. 2
- For Streptococcus pyogenes infections: Minimum 10 days to prevent acute rheumatic fever. 1, 2
- For pneumonia: 10 days total, with reassessment if no improvement by 48–72 hours. 1
- If fever persists beyond 48–72 hours or the child deteriorates, consider atypical pathogens and reevaluate. 1
Common Pitfalls to Avoid
- Do not underdose in high-risk scenarios: Children < 2 years, daycare attendees, or those with recent antibiotic exposure require the 90 mg/kg/day regimen, not the standard 45 mg/kg/day dose. 1
- Do not use amoxicillin alone for β-lactamase-producing organisms: If H. influenzae or Moraxella catarrhalis with β-lactamase production is suspected, switch to amoxicillin-clavulanate (90 mg/kg/day of amoxicillin component). 1
- Do not exceed maximum doses: The maximum daily dose is 4,000 mg/day regardless of weight. 1
- Ensure completion of therapy: Parents must complete the full prescribed course even if symptoms improve, particularly for streptococcal infections. 1
When to Escalate Therapy
- If no clinical improvement occurs within 48–72 hours, consider: 1
- Switching to amoxicillin-clavulanate for β-lactamase-producing organisms
- Adding a macrolide (azithromycin) for atypical pathogens
- Reevaluating the diagnosis and considering alternative pathogens or complications